Amgen 🧪🔬🧬

Competitive and predictable business climates fuel innovation, manufacturing and growth. @CNBC recognized Ohio and North Carolina as the top 2 states for business. Amgen is proud to have recently invested nearly $2 billion across both states to strengthen our U.S. manufacturing. This is what that investment looks like ⬇️

Amgen has invested nearly $2 billion in the U.S. over the last year, building on more than $40 billion invested in U.S. manufacturing and R&D since 2018. The TCJA, reinforced by the One Big Beautiful Bill Act, supports continued investment in domestic science and manufacturing.

Clinical trials are key to turning scientific discovery into new medicines for patients. We appreciate @HHSGov for convening a Clinical Trials Roundtable and discussing ways to reduce research barriers, expand access to research opportunities, and help bring innovation to patients faster.

What’s next for #biosimilars? At Amgen, continued development and manufacturing expertise is helping drive what’s ahead. Watch to learn more: amgen.ly/4eg6DdX

NC’s life sciences ecosystem is driving innovation, growth & opportunity. With more than $1.5 billion invested in the state, Amgen is proud to be part of that momentum. In @BusinessNC, Amgen's Paul Lewus shares how the Research Triangle can maintain its leadership in life sciences: amgen.ly/4vmEkRm

Ohio’s thriving manufacturing hub shows what’s possible when innovation, talent, and pro-growth tax policies align. We're proud to be part of this momentum, investing more than $1.4B in Ohio to help strengthen U.S. leadership in biotech. amgen.ly/3S2ARZd

NEWS: At #ADASciSessions 2026, we’re advancing the conversation around cardiometabolic care. New data reinforce the need for more integrated approaches to prevention, risk reduction, and long-term management across obesity, diabetes and cardiovascular disease. 🔗 Read more: amgen.ly/4uVXTQd $AMGN

@Tim46023972 We had messaged you on 4/1 to learn more. Could you please provide contact information to us so we can follow-up. Thank you.

@Amgen @AndrewYNg @BainandCompany Amgen, still no answers abt the autopen fail and possible allergic reaction? The injector was shipped back to you weeks ago....

How will AI shape the future of Amgen? CEO Bob Bradway recently joined Sarah Elk and AI pioneer @AndrewYNg on @BainandCompany's Winning with AI podcast to discuss how AI is helping accelerate innovation across drug discovery, development, and manufacturing. 🎙️Watch the full podcast: amgen.ly/4vym86Z $AMGN

People living with cardiometabolic conditions often face interconnected risks that can compound over time. This week at @AmDiabetesAssn’s #ADASciSessions, we’re helping advance the conversation around a more integrated approach to obesity, diabetes and cardiovascular disease and long-term management.

📢 Amgen announced the presentation of new data across rare autoimmune & inflammatory diseases at #EULAR2026. Research highlights IgG4-related disease & real-world evidence in ANCA-associated vasculitis. 🔗 Learn more: amgen.ly/4a8lyEu $AMGN

🔬 Small cell lung cancer news: Amgen’s DLL3-targeting therapy is now approved in the European Union for certain patients with extensive-stage small cell lung cancer (#SCLC). 🔗 Learn more: amgen.ly/4feYaZr

Cancer research doesn't stand still at Amgen. At #ASCO2026, we’re sharing new data in SCLC, colorectal cancer, prostate cancer, Ewing sarcoma & more. ➡️ Explore full abstracts: amgen.ly/43nAc7j

Amgen announced the planned retirement of EVP and CFO Peter Griffith. Thomas Dittrich will return to Amgen and succeed Griffith as CFO effective Sept. 1, 2026. “We are grateful to Peter for his leadership and lasting impact on the company,” said Chairman and CEO Robert A. Bradway. More: amgen.ly/4tOOxEm $AMGN

A major milestone in our more than $1.5 billion investment in Holly Springs, North Carolina. The final steel topping beam is now in place at Amgen’s newest advanced manufacturing facility — expanding U.S. biomanufacturing capabilities for the future. $AMGN

Headed to #ECO2026? Join us for our symposium and learn more about the evolving obesity treatment landscape. 🔗Learn more about our scientific approach to obesity: amgen.ly/4np5bZM

@Tim46023972 Hello, we've sent you a DM. Thank you.

@Tim46023972 Thank you for your message. We would like to contact you to learn more. Can you follow us back so we can send you a DM?

@Amgen My spouse developed horrible skin rash and hives after using Repatha. We are having to pay for your product side effects. Your autoinjector failed.

@CatLady_Anne Thank you for your message. We would like to contact you to learn more. Can you follow us back so we can send you a DM?

@Amgen Dangerous drug. Your teams are badly trained.

Amgen is investing an additional $300M in its U.S. manufacturing network to advance production capacity, enhance next-generation technologies and support a reliable supply of medicines. Total U.S. manufacturing investments announced over the past year now reach nearly $2B. 🔗See how Amgen is leading what’s next in biotech innovation: amgen.ly/4tPfB7l $AMGN

How do you navigate B-cell ALL at 21? After years of hospital stays & uncertainty, William is in remission. Now he’s helping other young people advocate for themselves. Read his story: amgen.ly/49pJfI3 @TheMightySite #AmgenSponsored